NEUROCRINE BIOSCIENCES INC (NBIX) /

The cash flow of NEUROCRINE BIOSCIENCES INC over the past 10 years

Chart NEUROCRINE BIOSCIENCES INC: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →

In fiscal 2025, the latest fiscal year on file, NEUROCRINE BIOSCIENCES INC's operating cash flow was $782.7M and its capital expenditures $34M, leaving free cash flow of $748.7M. Free cash flow was above zero in 8 of the 10 years shown. It ranged from -$110.29M in fiscal 2016 to $748.7M in fiscal 2025. Capital expenditures were highest in fiscal 2024, at $38.2M.

Year by year

Fiscal yearOperating cash flowCapital expendituresFree cash flow*
2025ended Dec 31, 2025$782.7M$34M$748.7M
2024ended Dec 31, 2024$595.4M$38.2M$557.2M
2023ended Dec 31, 2023$389.9M$28.3M$361.6M
2022ended Dec 31, 2022$339.4M$16.5M$322.9M
2021ended Dec 31, 2021$256.5M$23.4M$233.1M
2020ended Dec 31, 2020$228.5M$10.9M$217.6M
2019ended Dec 31, 2019$147M$14.7M$132.3M
2018ended Dec 31, 2018$101.4M$24.8M$76.6M
2017ended Dec 31, 2017-$94.33M$6.94M-$101.27M
2016ended Dec 31, 2016-$106.18M$4.11M-$110.29M

Fiscal years as NEUROCRINE BIOSCIENCES INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on NEUROCRINE BIOSCIENCES INC

Companies of a similar size

Not investment advice. This page shows what NEUROCRINE BIOSCIENCES INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.